Loading view.
Seminar – Cary Harding, MD – “Phenylketonuria: Insights into Pathophysiology and Novel Therapeutics”
John D. Wiley Conference CenterHarding's basic and clinical research programs are focused upon the development of novel therapies, including gene and cell therapies, for inborn errors of metabolism.
Free